Application of Proteomics in the Study of Toxicology and Toxic Markers of Traditional Chinese Medicines

IF 1.7 4区 医学 Q4 BIOCHEMICAL RESEARCH METHODS
Yang Yadi, Shang Ziyi, Hu Bin, Sun Ye, Li Jingjing, Ma Yujin, Jiang Hongwei, Liu Chuanxin, Li Xuejiao
{"title":"Application of Proteomics in the Study of Toxicology and Toxic Markers of Traditional Chinese Medicines","authors":"Yang Yadi,&nbsp;Shang Ziyi,&nbsp;Hu Bin,&nbsp;Sun Ye,&nbsp;Li Jingjing,&nbsp;Ma Yujin,&nbsp;Jiang Hongwei,&nbsp;Liu Chuanxin,&nbsp;Li Xuejiao","doi":"10.1002/bmc.70216","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>Proteomics is an omics emerging after genomics and transcriptomics, which plays a vital role in the fields of drug metabolism, pharmacotoxicology, toxicology, toxicodynamics, safety evaluation, and clinical medication. It provides a powerful tool for toxicity evaluation of TCM and its components, by systematically revealing toxicity mechanisms, identifying toxic biomarkers, and supporting toxicity prediction. This technology, by providing dynamic and functional information at the protein level, reveals key enzyme activities in drug metabolism and individual differences, identifies early toxicological markers and mechanisms, enhances safety evaluation comprehensiveness, and promotes clinical medication precision. This paper reviewed the application of proteomics in the research of toxicological mechanisms, toxicity biomarkers, and toxicity prediction of TCM to provide a reference for the study of toxicology and toxicity markers of TCM. In the future, proteomics will develop toward higher resolution, combine with artificial intelligence (AI) for deep data mining, and enhance multiomics data integration, enabling breakthroughs in dynamic disease monitoring, precise toxicity prediction, target discovery, and individualized diagnosis.</p>\n </div>","PeriodicalId":8861,"journal":{"name":"Biomedical Chromatography","volume":"39 10","pages":""},"PeriodicalIF":1.7000,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomedical Chromatography","FirstCategoryId":"3","ListUrlMain":"https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/bmc.70216","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0

Abstract

Proteomics is an omics emerging after genomics and transcriptomics, which plays a vital role in the fields of drug metabolism, pharmacotoxicology, toxicology, toxicodynamics, safety evaluation, and clinical medication. It provides a powerful tool for toxicity evaluation of TCM and its components, by systematically revealing toxicity mechanisms, identifying toxic biomarkers, and supporting toxicity prediction. This technology, by providing dynamic and functional information at the protein level, reveals key enzyme activities in drug metabolism and individual differences, identifies early toxicological markers and mechanisms, enhances safety evaluation comprehensiveness, and promotes clinical medication precision. This paper reviewed the application of proteomics in the research of toxicological mechanisms, toxicity biomarkers, and toxicity prediction of TCM to provide a reference for the study of toxicology and toxicity markers of TCM. In the future, proteomics will develop toward higher resolution, combine with artificial intelligence (AI) for deep data mining, and enhance multiomics data integration, enabling breakthroughs in dynamic disease monitoring, precise toxicity prediction, target discovery, and individualized diagnosis.

Abstract Image

Abstract Image

Abstract Image

蛋白质组学在中药毒理学及毒性标志物研究中的应用
蛋白质组学是继基因组学和转录组学之后兴起的一门组学,在药物代谢、药物毒理学、毒理学、毒理动力学、安全性评价、临床用药等领域发挥着重要作用。它通过系统地揭示毒性机制、识别毒性生物标志物和支持毒性预测,为中药及其成分的毒性评价提供了有力的工具。该技术通过提供蛋白质水平的动态和功能信息,揭示药物代谢关键酶活性和个体差异,识别早期毒理学标志物和毒理机制,提高安全性评价的全能性,提高临床用药精度。本文综述了蛋白质组学在中药毒理机制、毒性生物标志物和毒性预测研究中的应用,为中药毒理学和毒性标志物的研究提供参考。未来,蛋白质组学将向更高分辨率方向发展,结合人工智能进行深度数据挖掘,加强多组学数据整合,在疾病动态监测、毒性精准预测、靶点发现、个体化诊断等方面取得突破。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Biomedical Chromatography
Biomedical Chromatography 生物-分析化学
CiteScore
3.60
自引率
5.60%
发文量
268
审稿时长
2.3 months
期刊介绍: Biomedical Chromatography is devoted to the publication of original papers on the applications of chromatography and allied techniques in the biological and medical sciences. Research papers and review articles cover the methods and techniques relevant to the separation, identification and determination of substances in biochemistry, biotechnology, molecular biology, cell biology, clinical chemistry, pharmacology and related disciplines. These include the analysis of body fluids, cells and tissues, purification of biologically important compounds, pharmaco-kinetics and sequencing methods using HPLC, GC, HPLC-MS, TLC, paper chromatography, affinity chromatography, gel filtration, electrophoresis and related techniques.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信